Society for Immunotherapy of Cancer Announces Mary Dean, JD, CAE, as its Executive Director PRWeb FacebookTwitterEmail MILWAUKEE (PRWEB) January 25, 2021 The Society for Immunotherapy of Cancer (SITC), the world’s leading membership-driven organization dedicated solely to cancer immunotherapy, is pleased to announce that Mary Dean, JD, CAE, has been named Executive Director of the association. Ms. Dean steps into her new role after serving as the Associate Executive Director of SITC since February 2018, helping steward the strategic vision of the society as set forth by its members. She has more than 16 years of association experience. She spent the majority of those years serving as the Executive Director for the American Society of Gene & Cell Therapy, in addition to the Executive Director for the Society of Behavioral Medicine, American Venous Forum, and Growing Spine Foundation.